27 related articles for article (PubMed ID: 25168216)
1. Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
Prieto DA; Johann DJ; Wei BR; Ye X; Chan KC; Nissley DV; Simpson RM; Citrin DE; Mackall CL; Linehan WM; Blonder J
Biomark Med; 2014; 8(2):269-86. PubMed ID: 24521024
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer.
Nizioł J; Ossoliński K; Tripet BP; Copié V; Arendowski A; Ruman T
Anal Bioanal Chem; 2020 Sep; 412(23):5827-5841. PubMed ID: 32661677
[TBL] [Abstract][Full Text] [Related]
3. Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma.
Johann DJ; Wei BR; Prieto DA; Chan KC; Ye X; Valera VA; Simpson RM; Rudnick PA; Xiao Z; Issaq HJ; Linehan WM; Stein SE; Veenstra TD; Blonder J
Anal Chem; 2010 Mar; 82(5):1584-8. PubMed ID: 20121140
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.
Labots M; Schütte LM; van der Mijn JC; Pham TV; Jiménez CR; Verheul HM
Oncologist; 2014 Oct; 19(10):1028-39. PubMed ID: 25187478
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic Analysis of the Wound Peptidome Reveals Potential Biomarkers and Antimicrobial Peptides.
Hartman E; Wallblom K; van der Plas MJA; Petrlova J; Cai J; Saleh K; Kjellström S; Schmidtchen A
Front Immunol; 2020; 11():620707. PubMed ID: 33613550
[TBL] [Abstract][Full Text] [Related]
6. Proteomic approaches for characterizing renal cell carcinoma.
Clark DJ; Zhang H
Clin Proteomics; 2020; 17():28. PubMed ID: 32742246
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
[TBL] [Abstract][Full Text] [Related]
8. Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps.
Zheng H; Ji J; Zhao L; Chen M; Shi A; Pan L; Huang Y; Zhang H; Dong B; Gao H
Oncotarget; 2016 Sep; 7(37):59189-59198. PubMed ID: 27463020
[TBL] [Abstract][Full Text] [Related]
9. Proteomics and peptidomics: moving toward precision medicine in urological malignancies.
Di Meo A; Pasic MD; Yousef GM
Oncotarget; 2016 Aug; 7(32):52460-52474. PubMed ID: 27119500
[TBL] [Abstract][Full Text] [Related]
10. Serum and urine biomarkers for human renal cell carcinoma.
Pastore AL; Palleschi G; Silvestri L; Moschese D; Ricci S; Petrozza V; Carbone A; Di Carlo A
Dis Markers; 2015; 2015():251403. PubMed ID: 25922552
[TBL] [Abstract][Full Text] [Related]
11. Peptides in body fluids and tissues as markers of disease.
Schulte I; Tammen H; Selle H; Schulz-Knappe P
Expert Rev Mol Diagn; 2005 Mar; 5(2):145-57. PubMed ID: 15833045
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-mass spectrometry based serum peptidomic approach for renal clear cell carcinoma diagnosis.
Huang Z; Zhang S; Hang W; Chen Y; Zheng J; Li W; Xing J; Zhang J; Zhu E; Yan X
J Pharm Biomed Anal; 2014 Nov; 100():175-183. PubMed ID: 25168216
[TBL] [Abstract][Full Text] [Related]
13. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
